Your browser doesn't support javascript.
loading
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Kanemaru, Yu; Natsumeda, Manabu; Okada, Masayasu; Saito, Rie; Kobayashi, Daiki; Eda, Takeyoshi; Watanabe, Jun; Saito, Shoji; Tsukamoto, Yoshihiro; Oishi, Makoto; Saito, Hirotake; Nagahashi, Masayuki; Sasaki, Takahiro; Hashizume, Rintaro; Aoyama, Hidefumi; Wakai, Toshifumi; Kakita, Akiyoshi; Fujii, Yukihiko.
Afiliação
  • Kanemaru Y; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan.
  • Natsumeda M; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan. mnatsumeda@bri.niigata-u.ac.jp.
  • Okada M; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan.
  • Saito R; Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Kobayashi D; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan.
  • Eda T; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan.
  • Watanabe J; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan.
  • Saito S; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan.
  • Tsukamoto Y; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan.
  • Oishi M; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan.
  • Saito H; Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Nagahashi M; Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Sasaki T; Department of Neurosurgery, Northwestern University, Chicago, IL, USA.
  • Hashizume R; Department of Neurosurgery, Northwestern University, Chicago, IL, USA.
  • Aoyama H; Department of Radiology and Radiation Oncology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Wakai T; Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Kakita A; Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Fujii Y; From the Departments of Neurosurgery, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, Japan.
Acta Neuropathol Commun ; 7(1): 119, 2019 07 25.
Article em En | MEDLINE | ID: mdl-31345255

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / MAP Quinase Quinase Quinases / Ensaios Antitumorais Modelo de Xenoenxerto / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Commun Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / MAP Quinase Quinase Quinases / Ensaios Antitumorais Modelo de Xenoenxerto / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Commun Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão País de publicação: Reino Unido